Influenza Diagnostic–qpcr & Rapid Tests

Australia has had increasing record flu numbers so far, an elevated risk level of flu in Shenzhen to moderate, flu is raging around the country.
Influenza surveillance data released by both the World Health Organisation and the Chinese Centre for Disease Control and Prevention show that influenza activity has increased this year compared to the previous year. Since mid-May, there has been a rapid rise in influenza-like cases in China’s southern provinces, with influenza A (H3N2) subtype influenza viruses dominating. Experts point out that influenza prevention and control needs more attention under the novel coronavirus pneumonia epidemic.

*History of Influenza
The unusual and deadly influenza pandemic that broke out in Europe from January 1918 to December 1920 infected 500 million people, a quarter of the world’s population at the time, and killed between 17 million and 50 million people, making it the deadliest virus-induced epidemic in human history.

*What is influenza?
Influenza: The full name is influenza, an acute respiratory infection caused by the influenza virus. Influenza viruses, including influenza A, B and C. Influenza viruses often mutate, and there are many subtypes under each type. The common ones are Influenza A (H1N1) [referred to as New A1], Influenza A (H3N2) [referred to as A3], Influenza B (Victoria) [referred to as BV series] and Influenza B (Yamagata) [referred to as BY series], which are also the ones with the highest proportion of infection in the population. The current pandemic is influenza A. The predominant strain is “A3”, the A (H3N2) subtype of influenza virus. Influenza usually breaks out in a particular season, hence the common name seasonal influenza.

*What are the characteristics of influenza A?
1. Highly variable and difficult for the population to produce a continuous and stable immune barrier weakness, so it is highly contagious and easily spread by crowd gathering.
2. The symptoms are high fever, generalized pain, chills, fatigue, diarrhea, vomiting, etc. However, some cases may develop into severe influenza due to complications such as pneumonia, and a few severe cases may progress rapidly and die due to acute respiratory distress syndrome (ARDS) and/or multiple organ failure.

*Treatment and prevention and control?
1. Early diagnosis and treatment: There are now specific drugs for influenza viruses, such as oseltamivir, which can be administered in a timely manner to alleviate symptoms as soon as possible and prevent secondary infections and serious illnesses such as pneumonia, while avoiding the abuse of antibiotics.
2. Vaccinate actively to prevent illnesses before they occur: Every year, the International Health Organisation (WHO) identifies the predominant strains of influenza based on statistical analysis of influenza strains prevalent worldwide, and produces targeted vaccines. Therefore, active vaccination every year can greatly reduce the incidence of serious influenza illness.

Product Development

The current global situation in the prevention and control of the Newcastle pneumonia epidemic is still not to be underestimated, and the prevention and control of influenza under the epidemic requires even more attention. Effective triage of NCC and influenza will help to reduce the pressure on emergency outpatient clinics and reduce the cost of prevention and control, as well as being crucial to the immediate access of patients.
TargetingOne has three major technology platforms based on digital PCR, quantitative fluorescent PCR and immunization, including Novel coronavirus, Influenza A, Influenza B and Novel coronavirus/Influenza A/Influenza B combination test kits, and some of them have been qualified for export and overseas registration.

Cat.No. Product Name Specification Remark
13485 SARS-CoV-2 and Influenza A/B virus nucleic acid easyPCR detection kit 32 Tests RUO
13482 Influenza A/B virus nucleic acid easyPCR detection kit 8 Tests RUO
13480 Influenza A/B virus nucleic acid real-time PCR detection kit 8 Tests RUO
15016 SARS-CoV-2 and Influenza A/B Antigen Combo Test 1 test/Kit CE
15017 SARS-CoV-2 and Influenza A/B Antigen Combo Test 5 test/Kit CE
15018 SARS-CoV-2 and Influenza A/B Antigen Combo Test 25 test/Kit CE
15016-2 SARS-CoV-2 and Influenza A/B Antigen Combo Test 1 test/Kit CE
15017-2 SARS-CoV-2 and Influenza A/B Antigen Combo Test 5 test/Kit CE
15018-2 SARS-CoV-2 and Influenza A/B Antigen Combo Test 25 test/Kit CE
15131 Respiratory pathogens antigen combo test 1 Test / Kit CE
15132 Respiratory pathogens antigen combo test 5 Tests / Kit CE
15133 Respiratory pathogens antigen combo test 25 Tests / Kit CE
15134 Respiratory pathogens antigen combo test 1 Test / Kit CE
15135 Respiratory pathogens antigen combo test 5 Tests / Kit CE
15136 Respiratory pathogens antigen combo test 25 Tests / Kit CE